ALLMEDx | *:* - Agonists

2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and S...
https://doi.org/10.1016/j.cjca.2022.04.029
The Canadian Journal of Cardiology; Mancini GBJ, O'Meara E et. al.

Aug 13th, 2022 - This guideline synthesizes clinical trial data supporting the role of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter 2 inhibitors (SGLT2i) for treatment of heart failure (HF), chronic kidney disease, and for optimizing prevention of cardiorenal morbidity and mortality in patients with type 2 diabetes. It is on the basis of a companion systematic review and meta-anal...

Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
https://doi.org/10.1097/AOG.0000000000004401
Obstetrics and Gynecology;

May 21st, 2021 - Uterine leiomyomas (fibroids) are the most common solid and symptomatic neoplasm in women. They are the leading indication for hysterectomy (1, 2), which is a definitive and effective surgical treatment for leiomyoma. However, many patients benefit from and seek out management options other than hysterectomy because they desire future childbearing or wish to retain their uterus. The purpose of ...

Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Unde...
https://doi.org/10.1097/AOG.0000000000004209
Obstetrics and Gynecology;

Jan 6th, 2021 - Obstetrician-gynecologists frequently are consulted either before the initiation of cancer treatment to request menstrual suppression or during an episode of severe heavy bleeding to stop bleeding emergently. Adolescents presenting emergently with severe uterine bleeding usually require only medical management; surgical management rarely is required. Surgical management should be considered for...

Clinical and Investigative Endocrinology and Diabetes.
https://doi.org/10.4158/1934-2403-24.s2.1
Endocrine Practice : Official Journal of the American Col...

Nov 16th, 2018 - Clinical and Investigative Endocrinology and Diabetes.|2018||drug therapy,epidemiology,education,standards,trends,agonists,classification,therapeutic use,standards,

Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in pati...
https://doi.org/10.1002/nau.23314
Neurourology and Urodynamics; Phé V, Schneider MP et. al.

Jun 16th, 2017 - To systematically assess all available evidence on efficacy and safety of vanilloids for treating neurogenic lower urinary tract dysfunction (NLUTD) in patients with multiple sclerosis (MS). This systematic review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Studies were identified by electronic search of...

(7) Approaches to glycemic treatment.
https://doi.org/10.2337/dc15-S010
Diabetes Care;

Dec 30th, 2014 - (7) Approaches to glycemic treatment.|2014| ,|drug therapy,drug therapy,therapeutic use,agonists,therapeutic use,therapeutic use,therapeutic use,antagonists & inhibitors,therapeutic use,

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278070
Chest Garcia DA, Baglin TP et. al.

Feb 15th, 2012 - This article describes the pharmacology of approved parenteral anticoagulants. These include the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight heparins (LMWHs), fondaparinux, and danaparoid, as well as the direct thrombin inhibitors hirudin, bivalirudin, and argatroban. UFH is a heterogeneous mixture of glycosaminoglycans that bind to antithrombin via a unique pent...

Subtopics

Similar Searches